TRCURES
LIVE

Serial Number

98817905

Owner

Translational Cures, LLC

Attorney

David R. Schaffer

Filing Date

Oct 24, 2024

Add to watchlist:

No watchlists yet
View on USPTO

TRCURES Trademark

Serial Number: 98817905

TRCURES is a trademark filed by Translational Cures, LLC on October 24, 2024. The trademark is classified under Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Translational Cures, LLC (3 trademarks)

1209 Orange Street
Wilmington, DE 19801

Entity Type: 16

Trademark Details

Filing Date

October 24, 2024

Registration Date

Not Registered

Published for Opposition

June 3, 2025

Goods & Services

Providing online non-downloadable software and artificial intelligence (AI) tools for research and consulting; Non-downloadable software for pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product research and consulting; Non-downloadable computer modeling, simulation and artificial intelligence software tools for use in pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product research and development; Pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product development services; Consulting services, namely, product development research services in the fields of pharmaceutical, biotechnology, drug, chemical, medical products, and consumer products; Consulting services in the fields of pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product development research and development; Development and establishment of testing specifications and procedures for pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product industries; Development and establishment of testing specifications and procedures in the fields of pharmaceuticals, biotechnology, drugs, chemicals, medical products, and consumer products; Medical and scientific research in the fields of pharmaceutical, biotechnology, drug, chemical, medical products, and consumer products; Medical and scientific research and development using artificial intelligence in the fields of pharmaceutical, biotechnology, drug, chemical, medical products, and consumer products; Research and development in the fields of pharmaceutical, biotechnology, drug, chemical, medical products, and consumer products; Research and development using artificial intelligence in the fields of pharmaceutical, biotechnology, drug, chemical, medical products, and consumer products; Providing contract scientific research for others; Providing contract research in the pharmaceutical, drug, chemical, medical product, and consumer product industries for others

Providing Business Consulting and Strategic Services; Business consulting services in the pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product industries

Providing education, training, and workshop services, namely, conducting seminars and workshops in the fields of regulatory science, pharmaceuticals, biotechnology, drugs, chemicals, medical products, and consumer products; Training programs in regulatory science, pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product research methods

Providing custom manufacturing services

Providing regulatory consulting and legal compliance services; Providing regulatory consulting in the pharmaceutical, biotechnology, drug, chemical, medical product, and consumer product industries; Toxicity testing of pharmaceutical, biotechnology, drug, chemical, medical, and consumer products for medical purposes

Providing toxicity testing services, namely, testing of chemicals for others; Toxicity testing as part of the research and development of pharmaceutical, biotechnology, drug, chemical, medical, and consumer products for others

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 31, 2026 EXRA
SOU EXTENSION 1 GRANTED
Mar 30, 2026 EX1G
SOU EXTENSION 1 FILED
Mar 30, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 30, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 30, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 3, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 3, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 28, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
May 1, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 1, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
May 1, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 1, 2025 CNEA
ASSIGNED TO EXAMINER
Apr 25, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 24, 2025 NWOS
NEW APPLICATION ENTERED
Oct 24, 2024 NWAP